Literature DB >> 21880849

Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae.

Bernat de Val Pérez1, Sergio López-Soria, Miquel Nofrarías, Maite Martín, H Martin Vordermeier, Bernardo Villarreal-Ramos, Nadine Romera, Manel Escobar, David Solanes, Pere-Joan Cardona, Mariano Domingo.   

Abstract

Caprine tuberculosis (TB) has increased in recent years, highlighting the need to address the problem the infection poses in goats. Moreover, goats may represent a cheaper alternative for testing of prototype vaccines in large ruminants and humans. With this aim, a Mycobacterium caprae infection model has been developed in goats. Eleven 6-month-old goats were infected by the endobronchial route with 1.5 × 10(3) CFU, and two other goats were kept as noninfected controls. The animals were monitored for clinical and immunological parameters throughout the experiment. After 14 weeks, the goats were euthanized, and detailed postmortem analysis of lung lesions was performed by multidetector computed tomography (MDCT) and direct observation. The respiratory lymph nodes were also evaluated and cultured for bacteriological analysis. All infected animals were positive in a single intradermal comparative cervical tuberculin (SICCT) test at 12 weeks postinfection (p.i.). Gamma interferon (IFN-γ) antigen-specific responses were detected from 4 weeks p.i. until the end of the experiment. The humoral response to MPB83 was especially strong at 14 weeks p.i. (13 days after SICCT boost). All infected animals presented severe TB lesions in the lungs and associated lymph nodes. M. caprae was recovered from pulmonary lymph nodes in all inoculated goats. MDCT allowed a precise quantitative measure of TB lesions. Lesions in goats induced by M. caprae appeared to be more severe than those induced in cattle by M. bovis over a similar period of time. The present work proposes a reliable new experimental animal model for a better understanding of caprine tuberculosis and future development of vaccine trials in this and other species.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880849      PMCID: PMC3209027          DOI: 10.1128/CVI.05323-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  42 in total

1.  Field evaluation of a novel differential diagnostic reagent for detection of Mycobacterium bovis in cattle.

Authors:  P J Cockle; S V Gordon; R G Hewinson; H M Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2006-08-30

2.  Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species of free-ranging wildlife.

Authors:  K P Lyashchenko; R Greenwald; J Esfandiari; M A Chambers; J Vicente; C Gortazar; N Santos; M Correia-Neves; B M Buddle; R Jackson; D J O'Brien; S Schmitt; M V Palmer; R J Delahay; W R Waters
Journal:  Vet Microbiol       Date:  2008-07-07       Impact factor: 3.293

3.  Characterization of Mycobacterium caprae isolates from Europe by mycobacterial interspersed repetitive unit genotyping.

Authors:  Wolfgang M Prodinger; Anita Brandstätter; Ludmila Naumann; Maria Pacciarini; Tanja Kubica; Maria Laura Boschiroli; Alicia Aranaz; György Nagy; Zeljko Cvetnic; Matjaz Ocepek; Artem Skrypnyk; Wilfried Erler; Stefan Niemann; Ivo Pavlik; Irmgard Moser
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation of Mycobacterium bovis: I. Pathology and bacteriology.

Authors:  L A L Corner; E Costello; S Lesellier; D O'Meara; D P Sleeman; E Gormley
Journal:  Res Vet Sci       Date:  2007-01-02       Impact factor: 2.534

5.  Shedding of Mycobacterium bovis in the nasal mucus of cattle infected experimentally with tuberculosis by the intranasal and intratracheal routes.

Authors:  T McCorry; A O Whelan; M D Welsh; J McNair; E Walton; D G Bryson; R G Hewinson; H M Vordermeier; J M Pollock
Journal:  Vet Rec       Date:  2005-11-12       Impact factor: 2.695

6.  Early antibody responses to experimental Mycobacterium bovis infection of cattle.

Authors:  W R Waters; M V Palmer; T C Thacker; J P Bannantine; H M Vordermeier; R G Hewinson; R Greenwald; J Esfandiari; J McNair; J M Pollock; P Andersen; K P Lyashchenko
Journal:  Clin Vaccine Immunol       Date:  2006-06

Review 7.  Pathogenesis of bovine tuberculosis: the role of experimental models of infection.

Authors:  J M Pollock; J D Rodgers; M D Welsh; J McNair
Journal:  Vet Microbiol       Date:  2005-12-27       Impact factor: 3.293

8.  Spoligotype diversity of Mycobacterium bovis and Mycobacterium caprae animal isolates.

Authors:  E L Duarte; M Domingos; A Amado; A Botelho
Journal:  Vet Microbiol       Date:  2008-02-26       Impact factor: 3.293

9.  Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex.

Authors:  Ben Sidders; Chris Pirson; Philip J Hogarth; R Glyn Hewinson; Neil G Stoker; H Martin Vordermeier; Katie Ewer
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

10.  Mycobacterium caprae in cattle and humans in Croatia.

Authors:  Z Cvetnic; V Katalinic-Jankovic; B Sostaric; S Spicic; M Obrovac; S Marjanovic; M Benic; B K Kirin; I Vickovic
Journal:  Int J Tuberc Lung Dis       Date:  2007-06       Impact factor: 2.373

View more
  23 in total

1.  Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.

Authors:  Bernat Pérez de Val; Bernardo Villarreal-Ramos; Miquel Nofrarías; Sergio López-Soria; Nadine Romera; Mahavir Singh; F Xavier Abad; Zhou Xing; H Martin Vordermeier; Mariano Domingo
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

2.  Development of a Multiplex Bead Assay for Simultaneous Serodiagnosis of Antibodies against Mycobacterium bovis, Brucella suis, and Trichinella spiralis in Wild Boar.

Authors:  Antonia Touloudi; George Valiakos; Shaun Cawthraw; Polychronis Kostoulas; Christian Gortázar; Mariana Boadella; Alexios Giannakopoulos; Periklis Birtsas; Marina Sofia; Labrini V Athanasiou; Maria Satra; Zoi Athanasakopoulou; Maria Kantere; Vassiliki Spyrou; Liljana Petrovska; Charalambos Billinis
Journal:  Microorganisms       Date:  2021-04-23

3.  Seroprevalence and risk factors associated to Mycobacterium bovis in wild artiodactyl species from southern Spain, 2006-2010.

Authors:  Ignacio García-Bocanegra; Bernat Pérez de Val; Antonio Arenas-Montes; Jorge Paniagua; Mariana Boadella; Christian Gortázar; Antonio Arenas
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

4.  Effects of repeated comparative intradermal tuberculin testing on test results: a longitudinal study in TB-free red deer.

Authors:  Azlan Che-Amat; Maria Ángeles Risalde; David González-Barrio; Jose Antonio Ortíz; Christian Gortázar
Journal:  BMC Vet Res       Date:  2016-09-05       Impact factor: 2.741

5.  Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats.

Authors:  Enric Vidal; Claudia Arrieta-Villegas; Miriam Grasa; Irene Mercader; Mariano Domingo; Bernat Pérez de Val
Journal:  BMC Vet Res       Date:  2017-08-17       Impact factor: 2.741

6.  Oral Vaccination with Heat-Inactivated Mycobacterium bovis Does Not Interfere with the Antemortem Diagnostic Techniques for Tuberculosis in Goats.

Authors:  Alvaro Roy; María A Risalde; Carmen Casal; Beatriz Romero; Lucía de Juan; Ahmed M Menshawy; Alberto Díez-Guerrier; Ramon A Juste; Joseba M Garrido; Iker A Sevilla; Christian Gortázar; Lucas Domínguez; Javier Bezos
Journal:  Front Vet Sci       Date:  2017-08-07

7.  Effects of vaccination against paratuberculosis on tuberculosis in goats: diagnostic interferences and cross-protection.

Authors:  Bernat Pérez de Val; Miquel Nofrarías; Sergio López-Soria; Joseba M Garrido; H Martin Vordermeier; Bernardo Villarreal-Ramos; Maite Martín; Eugenia Puentes; Ramón A Juste; Mariano Domingo
Journal:  BMC Vet Res       Date:  2012-10-16       Impact factor: 2.741

8.  A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression.

Authors:  Bernat Pérez de Val; Enric Vidal; Bernardo Villarreal-Ramos; Sarah C Gilbert; Anna Andaluz; Xavier Moll; Maite Martín; Miquel Nofrarías; Helen McShane; H Martin Vordermeier; Mariano Domingo
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

Review 9.  The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies.

Authors:  Cristina Vilaplana; Pere-Joan Cardona
Journal:  Front Microbiol       Date:  2014-02-14       Impact factor: 5.640

10.  The Small Breathing Amplitude at the Upper Lobes Favors the Attraction of Polymorphonuclear Neutrophils to Mycobacterium tuberculosis Lesions and Helps to Understand the Evolution toward Active Disease in An Individual-Based Model.

Authors:  Pere-Joan Cardona; Clara Prats
Journal:  Front Microbiol       Date:  2016-03-29       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.